Nov-Dec 2008;14(6):24-6
doi: 10.2174/2211352519666210202085849 390 Sontsa-DonhoungAMBahdjolbeMHawaouNwagaD
There are virtually no data to inform best practice in the care of people with diabetes and advanced CKD, particularly in dialysis-dependent kidney disease
FIND YOUR SPARK AND REIGNITE THE PASSION

In experimental systems, it has been examined for its influence on multiple physiological processes relevant to energy balance : Glucose regulation : Studied for glucose-dependent stimulation of insulin secretion and suppression of glucagon release Gastrointestinal function : Investigated for delayed gastric emptying and altered gastrointestinal motility Energy intake and body weight : Evaluated in large phase 2 and 3 research programs, including the STEP (SemaglutidE Treatment Effect in People with obesity) trial series Cardiometabolic markers : Examined for changes in blood pressure, lipid parameters, and inflammatory biomarkers Renal and hepatic endpoints : Explored as secondary or exploratory outcomes in selected studies Within laboratory environments, Semaglutide (20 mg) is commonly used for: In vitro GLP-1 receptor signaling assays Pancreatic islet and -cell biology studies Preclinical models of food intake and body-weight regulation Formulation, stability, and delivery-technology research All applications remain investigational and are conducted under controlled research conditions

Reduction in Acne and Blemishes Its anti-inflammatory properties can assist in reducing acne outbreaks and minimizing blemishes, contributing to clearer skin